Promotion by tetrameric catechoylamide ligands and CaNa3-DTPA of the dissociation in vitro of the Pu-transferrin complex formed after intravenous injection of Pu-tri-N-butylphosphate.
D000818:Animals; D003666:Decontamination; D005260:Female; D008297:Male; D009942:Organometallic Compounds; D010755:Organophosphates / Q000097:blood*; D009943:Organophosphorus Compounds / Q000097:blood*; D010215:Papio; D004369:Pentetic Acid / Q000627:therapeutic use*; D011005:Plutonium / Q000097:blood*; D013095:Spermidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014168:Transferrin
D009942:Organometallic Compounds; D010755:Organophosphates; D009943:Organophosphorus Compounds; D014168:Transferrin; C038503:plutonium tri-n-butylphosphate complex; D011005:Plutonium; C030662:N,N',N''-tris(2,3-dihydroxy-5-sulfobenzoyl)-1,5,10-triazadecane; C034834:LICAM-C; D004369:Pentetic Acid; D013095:Spermidine